Sign in
4

Changes in Ownership

Kalaris Therapeutics, Inc. Filed Acc 0000950170-24-064052

Chief Executive Officer sold 5,149 shares at $0.79 ($4,080)

From the SEC's structured data for this filing

Trades in this filing

Brainard Diana · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-05-21 Sale : show line 1 in the form −5,149 $0.79 $4,080 784,471 D
Open-market sales · 5,149 sh · avg $0.79 · $4,080
Loading xslF345X05/ownership.xml…